Michael R Megna - Net Worth and Insider Trading

Michael R Megna Net Worth

The estimated net worth of Michael R Megna is at least $430,554 dollars as of 2024-10-05. Michael R Megna is the CHIEF ACCOUNTING OFFICER of Kiniksa Pharmaceuticals International PLC and owns about 17,588 shares of Kiniksa Pharmaceuticals International PLC (KNSA) stock worth over $430,554. Details can be seen in Michael R Megna's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael R Megna has not made any transactions after 2024-03-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Michael R Megna

To

Michael R Megna Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael R Megna owns 1 companies in total, including Kiniksa Pharmaceuticals International PLC (KNSA) .

Click here to see the complete history of Michael R Megna’s form 4 insider trades.

Insider Ownership Summary of Michael R Megna

Ticker Comapny Transaction Date Type of Owner
KNSA Kiniksa Pharmaceuticals International PLC 2024-03-01 Chief Accounting Officer

Michael R Megna Latest Holdings Summary

Michael R Megna currently owns a total of 1 stock. Michael R Megna owns 17,588 shares of Kiniksa Pharmaceuticals International PLC (KNSA) as of March 1, 2024, with a value of $430,554.

Latest Holdings of Michael R Megna

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KNSA Kiniksa Pharmaceuticals International PLC 2024-03-01 17,588 24.48 430,554

Holding Weightings of Michael R Megna


Michael R Megna Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael R Megna has made a total of 2 transactions in Kiniksa Pharmaceuticals International PLC (KNSA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Kiniksa Pharmaceuticals International PLC is the sale of 14,785 shares on March 1, 2024, which brought Michael R Megna around $318,912.

Insider Trading History of Michael R Megna

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael R Megna Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael R Megna Ownership Network

Ownership Network List of Michael R Megna

No Data

Ownership Network Relation of Michael R Megna

Insider Network Chart

Michael R Megna Owned Company Details

What does Kiniksa Pharmaceuticals International PLC do?

Who are the key executives at Kiniksa Pharmaceuticals International PLC?

Michael R Megna is the Chief Accounting Officer of Kiniksa Pharmaceuticals International PLC. Other key executives at Kiniksa Pharmaceuticals International PLC include Chief Business Officer Eben Tessari , Group VP & Rilonacept GM Ross Moat , and Chief Medical Officer John Paolini .

Kiniksa Pharmaceuticals International PLC (KNSA) Insider Trades Summary

Over the past 18 months, Michael R Megna made 2 insider transaction in Kiniksa Pharmaceuticals International PLC (KNSA) with a net sale of 24,101. Other recent insider transactions involving Kiniksa Pharmaceuticals International PLC (KNSA) include a net sale of 150,848 shares made by John Paolini , a net sale of 219,460 shares made by Sanj K Patel , and a net sale of 35,000 shares made by Eben Tessari .

In summary, during the past 3 months, insiders sold 346,570 shares of Kiniksa Pharmaceuticals International PLC (KNSA) in total and bought 0 shares, with a net sale of 346,570 shares. During the past 18 months, 522,163 shares of Kiniksa Pharmaceuticals International PLC (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 522,163 shares.

Kiniksa Pharmaceuticals International PLC (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kiniksa Pharmaceuticals International PLC Insider Transactions

No Available Data

Michael R Megna Mailing Address

Above is the net worth, insider trading, and ownership report for Michael R Megna. You might contact Michael R Megna via mailing address: 1050 Hingham Street, Rockland Ma 02370.

Discussions on Michael R Megna

No discussions yet.